Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Global Medical REIT ( (GMRE) ) has provided an update.
On October 8, 2025, Global Medical REIT Inc. announced a third amended and restated credit facility with JPMorgan Chase Bank, extending the maturity dates of its $400 million revolver and $350 million term loan, now divided into three tranches maturing between 2029 and 2031. The amendment removes a previous credit spread adjustment and maintains the pricing grid and $500 million accordion feature, resulting in an increased weighted average debt term from 1.3 years to 4.4 years, potentially enhancing the company’s financial stability and operational flexibility.
The most recent analyst rating on (GMRE) stock is a Hold with a $38.00 price target. To see the full list of analyst forecasts on Global Medical REIT stock, see the GMRE Stock Forecast page.
Spark’s Take on GMRE Stock
According to Spark, TipRanks’ AI Analyst, GMRE is a Neutral.
Global Medical REIT’s overall score reflects strong financial performance and strategic growth initiatives. However, high valuation metrics and challenges such as dividend reduction and credit facility renewal weigh on the score. The technical analysis suggests a neutral market position, while the attractive dividend yield provides some support.
To see Spark’s full report on GMRE stock, click here.
More about Global Medical REIT
Global Medical REIT Inc. is a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases them to physician groups and regional and national healthcare systems.
Average Trading Volume: 173,000
Technical Sentiment Signal: Sell
Current Market Cap: $615.5M
For an in-depth examination of GMRE stock, go to TipRanks’ Overview page.